Arias-Carrión O, Stamelou M, Murillo-Rodríguez E, Menéndez-González M, Pöppel E (2010) Dopaminergic reward system: a short integrative review. Int Arch Med 3:24. https://doi.org/10.1186/1755-7682-3-24

Barbosa-Silva MC, Campos P, Del Castilo RM, França I, Frost JV, Penido PS et al (2022) Mice lacking 5-lipoxygenase display motor deficits associated with cortical and hippocampal synapse abnormalities. Brain Behav Immun 100:183–193. https://doi.org/10.1016/j.bbi.2021.12.004

Article  CAS  PubMed  Google Scholar 

Bendani MK, Palluy O, Cook-Moreau J, Beneytout JL, Rigaud M, Vallat JM (1995) Localization of 12-lipoxygenase mRNA in cultured oligodendrocytes and astrocytes by in situ reverse transcriptase and polymerase chain reaction. Neurosci Lett 189(3):159–162. https://doi.org/10.1016/0304-3940(95)11482-c

Article  CAS  PubMed  Google Scholar 

Bergman H, Soares-Weiser K (2018) Anticholinergic medication for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev 1(1):CD000204. https://doi.org/10.1002/14651858.CD000204.pub2

Article  PubMed  Google Scholar 

Bilbo SD, Schwarz JM (2009) Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 3:14

Article  PubMed  PubMed Central  Google Scholar 

Calabresi P, Giacomini P, Centonze D, Bernardi G (2000) Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol 47:S60–S69

CAS  PubMed  Google Scholar 

Chen H, Manev H (2011) Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient mice. Neuropharmacology 60(7–8):1058–1063. https://doi.org/10.1016/j.neuropharm.2010.09.006

Article  CAS  PubMed  Google Scholar 

Chou VP, Holman TR, Manning-Bog AB (2013) Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. Neurosci 3(228):73–82. https://doi.org/10.1016/j.neuroscience.2012.10.009

Article  CAS  Google Scholar 

Chu J, Praticò D (2009) The 5-lipoxygenase as a common pathway for pathological brain and vascular aging. Cardiovasc Psychiatr Neurol 2009:174657. https://doi.org/10.1155/2009/174657

Article  CAS  Google Scholar 

Chu J, Praticò D (2011) Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzeheimer’s disease transgenic mouse model involvement of gamma-secretase. Am J Path 178:1762–1769

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu J, Praticò D (2016) The 5-Lipoxygenase as modulator of Alzheimer’s γ-secretase and therapeutic target. Brain Res Bull 126(2):207–212. https://doi.org/10.1016/j.brainresbull.2016.03.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cunha AS, Matheus FC, Moretti M, Sampaio TB, Poli A, Santos DB et al (2016) Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide and glutamate NMDA receptors. Behav Brain Res 1(312):64–76. https://doi.org/10.1016/j.bbr.2016.06.014

Article  CAS  Google Scholar 

Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn’t do. Curr Opin Pharmacol 7(1):69–76

Article  PubMed  Google Scholar 

Diz-Chaves Y, Pernía O, Carrero P, Garcia-Segura LM (2012) Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J. Neuroinflammation 9:71. https://doi.org/10.1186/1742-2094-9-71

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrari DP, Bortolanza M, Del Bel EA (2021) Interferon-γ involvement in the Neuroinflammation Associated with Parkinson’s disease and L-DOPA-Induced Dyskinesia. Neurotox Res 39(3):705–719. https://doi.org/10.1007/s12640-021-00345-x

Article  CAS  PubMed  Google Scholar 

Funk CD, Chen XS (2000) 5-Lipoxygenase and Leukotrienes Transgenic Mouse and Nuclear Targeting studies. Am J Respir Crit Care Med 161:S120–S124 Internet address: www.atsjournals.org

Article  CAS  PubMed  Google Scholar 

Giannopoulos PF, Chiu J, Praticò D (2019) Learning impairments, memory deficits, and neuropathology in aged tau transgenic mice are dependent on Leukotrienes Biosynthesis: role of the cdk5 kinase pathway. Mol Neurobiol 56(2):1211–1220. https://doi.org/10.1007/s12035-018-1124-7

Article  CAS  PubMed  Google Scholar 

Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K et al (2019) Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun 76:268–274. https://doi.org/10.1016/j.bbi.2018.11.315

Article  CAS  PubMed  Google Scholar 

Issy AC, Salum C, Del Bel EA (2009) Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice. Behav Brain Reseasch 205(2):475–481. https://doi.org/10.1016/j.bbr.2009.08.003

Article  CAS  Google Scholar 

Issy AC, Nascimento GC, Abreu GHD, Tristão FS, Del-Bel E, Duarte T et al (2018) Differential behavioral and glial responses induced by dopaminergic mechanisms in the iNOS knockout mice. Behav Brain Res 17(350):44–53. https://doi.org/10.1016/j.bbr.2018.05.002

Article  CAS  Google Scholar 

Issy AC, Pedrazzi JFC, van Oosten ABS, Checheto T, Silva RR, Noël F et al (2020) Effects of doxycycline in Swiss mice predictive models of Schizophrenia. Neurotox Res 38(4):1049–1060. https://doi.org/10.1007/s12640-020-00268-z

Article  CAS  PubMed  Google Scholar 

Jenner P, Katzenschlager R (2016) Apomorphine - pharmacological properties and clinical trials in Parkinson’s disease. Parkinsonism Relat Disord 33(Suppl 1):S13–S21. https://doi.org/10.1016/j.parkreldis.2016.12.003

Article  PubMed  Google Scholar 

Joshi YB, Praticò D (2013) The involvement of 5-lipoxygenase activating protein in anxiety-like behavior. J Psychiatr Res 47(5):694–698. https://doi.org/10.1016/j.jpsychires.2012.12.011

Article  PubMed  PubMed Central  Google Scholar 

Kahnt AS, Rörsch F, Diehl O, Hofmann B, Lehmann C, Steinbrink SD et al (2013) Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity. Biochem Pharmacol 86(2):286–296. https://doi.org/10.1016/j.bcp.2013.05.005

Article  CAS  PubMed  Google Scholar 

Kahnt AS, Angioni C, Göbel T, Hofmann B, Roos J, Steinbrink SD et al (2022) Inhibitors of human 5-Lipoxygenase potently interfere with prostaglandin transport. Front Pharmacol 21(12):782584. https://doi.org/10.3389/fphar.2021.782584

Article  CAS  Google Scholar 

Kang KH, Liou HH, Hour MJ, Liou HC, Fu WM (2013) Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology 73:380–387. https://doi.org/10.1016/j.neuropharm.2013.06.014

Article  CAS  PubMed  Google Scholar 

Kerttula T, Riutta A, Kaukinen S, Metsä-Ketelä T, Seppälä E, Vapaatalo H et al (1995) Noradrenaline and dopamine infusions modulate arachidonic acid cyclooxygenase and 5-lipoxygenase pathways ex vivo in man. Prostaglandins Leukot Essent Fat Acids 53(1):47–52. https://doi.org/10.1016/0952-3278(95)90082-9

Article  CAS  Google Scholar 

Kouli A, Camacho M, Allinson K, Williams-Gray CH (2020) Neuroinflammation and protein pathology in Parkinson’s disease dementia. Acta Neuropathol Commun 8(1):211. https://doi.org/10.1186/s40478-020-01083-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kursun O, Karatas H, Bariskaner H, Ozturk S (2022) Arachidonic acid metabolites in neurologic disorders. CNS Neurol Disord Drug Targets 21(2):150–159. https://doi.org/10.2174/1871527320666210512013648

Article  CAS  PubMed  Google Scholar 

Kurtuncu M, Battista N, Uz T, D’Agostino A, Dimitrijevic N, Pasquariello N et al (2008) Effects of cocaine in 5-lipoxygenase-deficient mice. J Neural Transm 115(3):389–395. https://doi.org/10.1007/s00702-007-0848-8

Article  CAS